Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shi-Nan Luong, Anthony Isaacs, Zhixin Liu, Fang E Sin & Ian Giles. (2020) A systematic review and meta-analysis of the gonadotoxic effects of cyclophosphamide and benefits of gonadotropin releasing hormone agonists (GnRHa) in women of child-bearing age with autoimmune rheumatic disease. Expert Review of Clinical Immunology 16:3, pages 321-333.
Read now
Read now
Zeev Blumenfeld. (2012) Preservation of ovarian function and fertility despite gonadotoxic chemotherapy. Expert Review of Endocrinology & Metabolism 7:5, pages 567-576.
Read now
Read now
Articles from other publishers (43)
Saleha Dar, Sabina Koirala, Arooba Khan, Mounika Deepthi Bellary, Arya V Patel, Bejoi Mathew, Rahul Singh, Nahida Baigam, Waleed Razzaq, Zain U Abdin & Uzzam Ahmed Khawaja. (2023) A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations. Cureus.
Crossref
Crossref
T. S. Panevin, T. V. Popkova, T. M. Reshetnyak, N. M. Kosheleva & A. V. Ledina. (2023) Menopausal hormone therapy in systemic lupus erythematosus: Pro et contra. Rheumatology Science and Practice 61:1, pages 70-76.
Crossref
Crossref
S. Giambalvo, C. Garaffoni, E. Silvagni, F. Furini, R. Rizzo, M. Govoni & A. Bortoluzzi. (2022) Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmunity Reviews 21:4, pages 103038.
Crossref
Crossref
Danica H. Chang, Sandra M. Dumanski & Sofia B. Ahmed. (2022) Female Reproductive and Gynecologic Considerations in Chronic Kidney Disease: Adolescence and Young Adulthood. Kidney International Reports 7:2, pages 152-164.
Crossref
Crossref
Melanie Henes, Michael von Wolff & Joerg Henes. 2022. Female and Male Fertility Preservation. Female and Male Fertility Preservation
217
223
.
Mitali Sen, Anu Kurl & Arezou Khosroshahi. (2021) Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy. Lupus 30:9, pages 1509-1514.
Crossref
Crossref
Mengtao Li, Yan Zhao, Zhiyi Zhang, Cibo Huang, Yi Liu, Jieruo Gu, Xiao Zhang, Huji Xu, Xiaofeng Li, Lijun Wu, Yijun Song, Xuemei Li, Hongzhong Jin, Junqiang Lei, Yaolong Chen & Xiaofeng Zeng. (2020) 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus. Rheumatology and Immunology Research 1:1, pages 5-23.
Crossref
Crossref
Meghan Angley, Jessica B Spencer, S Sam Lim & Penelope P Howards. (2020) Anti-Müllerian hormone in African-American women with systemic lupus erythematosus. Lupus Science & Medicine 7:1, pages e000439.
Crossref
Crossref
Richard A Anderson, Frédéric Amant, Didi Braat, Arianna D'Angelo, Susana M Chuva de Sousa Lopes, Isabelle Demeestere, Sandra Dwek, Lucy Frith, Matteo Lambertini, Caroline Maslin, Mariana Moura-Ramos, Daniela Nogueira, Kenny Rodriguez-Wallberg & Nathalie Vermeulen. (2020) ESHRE guideline: female fertility preservation†. Human Reproduction Open 2020:4.
Crossref
Crossref
Emily C. Somers. (2020) Pregnancy and autoimmune diseases. Best Practice & Research Clinical Obstetrics & Gynaecology 64, pages 3-10.
Crossref
Crossref
Ruba Kado & W. Joseph McCune. (2020) Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosus. Best Practice & Research Clinical Obstetrics & Gynaecology 64, pages 97-106.
Crossref
Crossref
Melanie Henes, Michael von Wolff & Joerg Henes. 2020. Fertility Preservation in Oncological and Non-Oncological Diseases. Fertility Preservation in Oncological and Non-Oncological Diseases
123
131
.
Alexander Kucherov & Erkan Buyuk. 2020. Diminished Ovarian Reserve and Assisted Reproductive Technologies. Diminished Ovarian Reserve and Assisted Reproductive Technologies
13
38
.
T. V. Popkova, T. A. Panafidina & S. K. Solovyev. (2019) According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments. Rheumatology Science and Practice 57:5, pages 496-510.
Crossref
Crossref
Nigar Sofiyeva, Timo Siepmann, Kristian Barlinn, Emre Seli & Baris Ata. (2019) Gonadotropin-Releasing Hormone Analogs for Gonadal Protection During Gonadotoxic Chemotherapy: A Systematic Review and Meta-Analysis. Reproductive Sciences 26:7, pages 939-953.
Crossref
Crossref
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg Bajema, John N Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni, Frédéric Houssiau, David Jayne, Marios Kouloumas, Annegret Kuhn, Janni L Larsen, Kirsten Lerstrøm, Gabriella Moroni, Marta Mosca, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Vladimir Tesar, Angela Tincani, Anne Troldborg, Ronald van Vollenhoven, Jörg Wenzel, George Bertsias & Dimitrios T Boumpas. (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases 78:6, pages 736-745.
Crossref
Crossref
Margherita Condorelli & Isabelle Demeestere. (2019) Challenges of fertility preservation in non‐oncological diseases. Acta Obstetricia et Gynecologica Scandinavica 98:5, pages 638-646.
Crossref
Crossref
Sandra Marie Dumanski & Sofia Bano Ahmed. (2019) Fertility and reproductive care in chronic kidney disease. Journal of Nephrology 32:1, pages 39-50.
Crossref
Crossref
Véronique Le Guern. 2019. La Ménopause en Pratique. La Ménopause en Pratique
131
136
.
Tomohiro Koga, Masataka Umeda, Yushiro Endo, Midori Ishida, Yuya Fujita, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Takashi Igawa, Shoichi Fukui, Ayako Nishino, Shin-ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Naoko Murakami, Michio Kitajima & Atsushi Kawakami. (2018) Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study. International Journal of Rheumatic Diseases 21:6, pages 1287-1292.
Crossref
Crossref
A. N. Schüring, T. Fehm, K. Behringer, M. Goeckenjan, P. Wimberger, M. Henes, J. Henes, M. F. Fey & M. von Wolff. (2017) Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation. Archives of Gynecology and Obstetrics 297:1, pages 241-255.
Crossref
Crossref
Sofia B. Ahmed, Wendy S. Vitek & Jean L. Holley. (2017) Fertility, Contraception, and Novel Reproductive Technologies in Chronic Kidney Disease. Seminars in Nephrology 37:4, pages 327-336.
Crossref
Crossref
Mitali Talsania & Robert Hal Scofield. (2017) Menopause and Rheumatic Disease. Rheumatic Disease Clinics of North America 43:2, pages 287-302.
Crossref
Crossref
Emily C. Somers & Wendy Marder. (2017) Infertility – Prevention and Management. Rheumatic Disease Clinics of North America 43:2, pages 275-285.
Crossref
Crossref
Allison L. Goetsch, Dana Kimelman & Teresa K. WoodruffAllison L. Goetsch, Dana Kimelman & Teresa K. Woodruff. 2017. Fertility Preservation and Restoration for Patients with Complex Medical Conditions. Fertility Preservation and Restoration for Patients with Complex Medical Conditions
141
169
.
Leena Nahata, Vidya Sivaraman & Gwendolyn P. Quinn. (2016) Fertility counseling and preservation practices in youth with lupus and vasculitis undergoing gonadotoxic therapy. Fertility and Sterility 106:6, pages 1470-1474.
Crossref
Crossref
Ozgur Oktem, Hande Yagmur, Hale Bengisu & Bulent Urman. (2016) Reproductive aspects of systemic lupus erythematosus. Journal of Reproductive Immunology 117, pages 57-65.
Crossref
Crossref
Maurício Barbour Chehin. (2016) Preservação da fertilidade em mulheres no contexto reumatológico – aspectos atuais da reprodução assistida. Revista Paulista de Reumatologia:2016 abr-jun;15(2), pages 26-31.
Crossref
Crossref
J Mayorga, D Alpízar-Rodríguez, J Prieto-Padilla, J Romero-Díaz & M C Cravioto. (2015) Prevalence of premature ovarian failure in patients with systemic lupus erythematosus. Lupus 25:7, pages 675-683.
Crossref
Crossref
Wendy Marder, Emily A. Littlejohn & Emily C. Somers. (2016) Pregnancy and autoimmune connective tissue diseases. Best Practice & Research Clinical Rheumatology 30:1, pages 63-80.
Crossref
Crossref
I. V. Kuznetsova. (2016) Preservation of ovarian reserve in patients with endometriosis. Problemy reproduktsii 22:4, pages 37.
Crossref
Crossref
Jinjin Zhang, Li Fang, Zhiyong Lu, Jiaqiang Xiong, Meng Wu, Liangyan Shi, Aiyue Luo & Shixuan Wang. (2016) Are sirtuins markers of ovarian aging?. Gene 575:2, pages 680-686.
Crossref
Crossref
Marisa Klein-Gitelman & Jerome Charles Lane. 2016. Textbook of Pediatric Rheumatology. Textbook of Pediatric Rheumatology
285
317.e14
.
Sandro Barni, Elena Collovà, Antonio Frassoldati & Domenico Amoroso. (2015) Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologists. Future Oncology 11:8, pages 1181-1189.
Crossref
Crossref
P. Orquevaux, A. Masseau, V. Le Guern, V. Gayet, D. Vauthier, D. Boutin, B. Wechsler, N. Morel, G. Guettrot-Imbert, J.-L. Pennaforte, J.-C. Piette & N. Costedoat-Chalumeau. (2015) Fécondation in vitro au cours du lupus érythémateux systémique ou du syndrome des antiphospholipides : mise au point. La Revue de Médecine Interne 36:3, pages 154-158.
Crossref
Crossref
María del Carmen Velarde-Ochoa, Jorge Antonio Esquivel-Valerio, David Vega-Morales, Cassandra Michele Skinner-Taylor, Dionicio Ángel Galarza-Delgado & Mario Alberto Garza-Elizondo. (2015) Anti-müllerian Hormone in Reproductive Age Women With Systemic Lupus Erythematosus. Reumatología Clínica (English Edition) 11:2, pages 78-82.
Crossref
Crossref
María del Carmen Velarde-Ochoa, Jorge Antonio Esquivel-Valerio, David Vega-Morales, Cassandra Michele Skinner-Taylor, Dionicio Ángel Galarza-Delgado & Mario Alberto Garza-Elizondo. (2015) Hormona anti-mülleriana en mujeres en edad reproductiva con lupus eritematoso sistémico. Reumatología Clínica 11:2, pages 78-82.
Crossref
Crossref
Sandra Gofinet Pasoto. (2013) Ovarian Reserve in Systemic Lupus Erythematosus Patients with Normal Menstrual Cycles and in the Absence of Exposure to Alkylating Agents. Journal of Women's Health 22:12, pages 1003-1004.
Crossref
Crossref
Nathalie Morel, Anne Bachelot, Zeina Chakhtoura, Pascale Ghillani-Dalbin, Zahir Amoura, Lionel Galicier, Olivier Aumaitre, Jean-Charles Piette, Jacques Pourrat, Du Boutin, Karim Sacre, Jean-Emmanuel Kahn, Pierre Duhaut, Dominique Farge, Camille Francès, Gaëlle Guettrot-Imbert, Jean-Robert Harlé, Olivier Lambotte, Véronique Le Guern, Damien Sène, Salim Trad, Elisabeth Vidal, Francoise Sarrot-Reynauld, Anne Gompel, Marie-Laure Tanguy, Philippe Touraine, Jean-Marc Lacorte & Nathalie Costedoat-Chalumeau. (2013) Study of Anti-Müllerian Hormone and Its Relation to the Subsequent Probability of Pregnancy in 112 Patients With Systemic Lupus Erythematosus, Exposed or Not to Cyclophosphamide. The Journal of Clinical Endocrinology & Metabolism 98:9, pages 3785-3792.
Crossref
Crossref
JOSEPHINE ISGRO, SAHADAT K. NURUDEEN, LISA F. IMUNDO, MARK V. SAUER & NATAKI C. DOUGLAS. (2013) Cyclophosphamide Exposure in Pediatric Systemic Lupus Erythematosus Is Associated with Reduced Serum Anti-Müllerian Hormone Levels. The Journal of Rheumatology 40:6, pages 1029-1031.
Crossref
Crossref
Shakuntala ChhabraImran Kutchi. (2013) Fertility Preservation in Gynecological Cancers. Clinical Medicine Insights: Reproductive Health 7, pages CMRH.S10794.
Crossref
Crossref
LE Harward, K Mitchell, C Pieper, S Copland, LG Criscione-Schreiber & MEB Clowse. (2012) The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease. Lupus 22:1, pages 81-86.
Crossref
Crossref
Wendy MarderSenait FissehaMartha A. GanserEmily C. Somers. (2012) Ovarian Damage during Chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility. Clinical Medicine Insights: Reproductive Health 6, pages CMRH.S10415.
Crossref
Crossref